LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: A Comprehensive Review of Risk Factors for Venous Thromboembolism: From Epidemiology to Pathophysiology.

    Pastori, Daniele / Cormaci, Vito Maria / Marucci, Silvia / Franchino, Giovanni / Del Sole, Francesco / Capozza, Alessandro / Fallarino, Alessia / Corso, Chiara / Valeriani, Emanuele / Menichelli, Danilo / Pignatelli, Pasquale

    International journal of molecular sciences

    2023  Volume 24, Issue 4

    Abstract: Venous thromboembolism (VTE) is the third most common cause of death worldwide. The incidence of VTE varies according to different countries, ranging from 1-2 per 1000 person-years in Western Countries, while it is lower in Eastern Countries (<1 per 1000 ...

    Abstract Venous thromboembolism (VTE) is the third most common cause of death worldwide. The incidence of VTE varies according to different countries, ranging from 1-2 per 1000 person-years in Western Countries, while it is lower in Eastern Countries (<1 per 1000 person-years). Many risk factors have been identified in patients developing VTE, but the relative contribution of each risk factor to thrombotic risk, as well as pathogenetic mechanisms, have not been fully described. Herewith, we provide a comprehensive review of the most common risk factors for VTE, including male sex, diabetes, obesity, smoking, Factor V Leiden, Prothrombin G20210A Gene Mutation, Plasminogen Activator Inhibitor-1, oral contraceptives and hormonal replacement, long-haul flight, residual venous thrombosis, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, trauma and fractures, pregnancy, immobilization, antiphospholipid syndrome, surgery and cancer. Regarding the latter, the incidence of VTE seems highest in pancreatic, liver and non-small cells lung cancer (>70 per 1000 person-years) and lowest in breast, melanoma and prostate cancer (<20 per 1000 person-years). In this comprehensive review, we summarized the prevalence of different risk factors for VTE and the potential molecular mechanisms/pathogenetic mediators leading to VTE.
    MeSH term(s) Female ; Humans ; Male ; Venous Thromboembolism/genetics ; COVID-19 ; SARS-CoV-2 ; Risk Factors ; Venous Thrombosis/genetics ; Thrombophilia/genetics
    Language English
    Publishing date 2023-02-05
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms24043169
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Risk of venous thromboembolism in autoimmune diseases: A comprehensive review.

    Menichelli, Danilo / Cormaci, Vito Maria / Marucci, Silvia / Franchino, Giovanni / Del Sole, Francesco / Capozza, Alessandro / Fallarino, Alessia / Valeriani, Emanuele / Violi, Francesco / Pignatelli, Pasquale / Pastori, Daniele

    Autoimmunity reviews

    2023  Volume 22, Issue 11, Page(s) 103447

    Abstract: Autoimmune diseases have specific pathophysiologic mechanisms leading to an increased risk of arterial and venous thrombosis. The risk of venous thromboembolism (VTE) varies according to the type and stage of the disease, and to concomitant treatments. ... ...

    Abstract Autoimmune diseases have specific pathophysiologic mechanisms leading to an increased risk of arterial and venous thrombosis. The risk of venous thromboembolism (VTE) varies according to the type and stage of the disease, and to concomitant treatments. In this review, we revise the most common autoimmune disease such as antiphospholipid syndrome, inflammatory myositis, polymyositis and dermatomyositis, rheumatoid arthritis, sarcoidosis, Sjogren syndrome, autoimmune haemolytic anaemia, systemic lupus erythematosus, systemic sclerosis, vasculitis and inflammatory bowel disease. We also provide an overview of pathophysiology responsible for the risk of VTE in each autoimmune disorder, and report current indications to anticoagulant treatment for primary and secondary prevention of VTE.
    MeSH term(s) Humans ; Venous Thromboembolism/complications ; Venous Thromboembolism/epidemiology ; Autoimmune Diseases/complications ; Autoimmune Diseases/epidemiology ; Arthritis, Rheumatoid/complications ; Antiphospholipid Syndrome/complications ; Lupus Erythematosus, Systemic/complications
    Language English
    Publishing date 2023-09-14
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 2144145-5
    ISSN 1873-0183 ; 1568-9972
    ISSN (online) 1873-0183
    ISSN 1568-9972
    DOI 10.1016/j.autrev.2023.103447
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top